SCHEMBL8104827

SCHEMBL8104827

COC(=O)CCCCC(S)CCC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
KMT2A Q03164 3/20 0.38
PABPC1 P11940 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
RECQL P46063 1/20 0.36
PPARG P37231 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 2/20 0.33
SLC1A1 P43005 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29129028 0.89 TSHR (0.56) TSHRL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL15954875 0.89 TSHR (0.56) TSHRL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL7778506 0.84 TSHR (0.50) TSHRL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL18681871 0.82 LMNA (0.50) TSHRL3MBTL1LMNAALDH1A1PPARG
SCHEMBL17173340 0.82 LMNA (0.50) TSHRL3MBTL1LMNAALDH1A1PPARG
SCHEMBL8416314 0.82 LMNA (0.50) TSHRL3MBTL1LMNAALDH1A1PPARG
SCHEMBL17173344 0.81 PPARG (0.49) TSHRL3MBTL1LMNAALDH1A1PPARG
SCHEMBL7794217 0.80 TSHR (0.42) TSHRL3MBTL1LMNAALDH1A1KMT2A
SCHEMBL8897102 0.79 ZDHHC7 (0.47) TSHRL3MBTL1LMNAKMT2ARECQL
SCHEMBL1706595 0.78 TSHR (0.70) TSHRLMNAALDH1A1MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed